GlassScriptPhysician profile
Bashar J Markabawi
NPI 1518968429
$11,829.80
in general payments reported to CMS, 2019-2025
51 companies · $1,368 in 2025
The $1,368 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,780 · 2020: $1,558 · 2021: $1,519 · 2022: $1,951 · 2023: $2,135 · 2024: $1,519 · 2025: $1,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,849 · Debt Forgiveness: $93.06 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,849.11 |
| Debt Forgiveness | $93.06 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,126.67 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $777.05 | 2019-2024 | Xarelto |
| Abbott Laboratories | $770.91 | 2019-2025 | Cardiomems, Aveir, Jot Dx |
| Bardy Diagnostics, INC. | $710.00 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $676.07 | 2019-2025 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $564.08 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $511.14 | 2019-2024 | Brilinta, Farxiga, Andexxa |
| Merck Sharp & Dohme LLC | $497.51 | 2021-2025 | Verquvo, Winrevair |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $458.33 | 2019-2023 | Lifevest |
| Amgen INC. | $457.76 | 2019-2023 | Repatha |
| Baxter Healthcare | $456.79 | 2022-2024 | Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $430.96 | 2019-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $426.37 | 2019-2025 | Watchman Flx, Rotapro, Varithena Administration Pack |
| Pfizer INC. | $385.49 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $338.34 | 2019-2024 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $329.01 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amarin Pharma, INC. | $328.42 | 2019-2022 | |
| Heartflow, INC. | $224.98 | 2024-2025 | |
| Biotronik INC. | $213.17 | 2020-2025 | Biomonitor |
| Kestra Medical Technology Services, INC. | $204.21 | 2023-2025 | Assure Wcd |
| Astellas Pharma US INC | $180.17 | 2019-2021 | |
| Atricure, INC. | $158.02 | 2022-2024 | |
| Chiesi USA, INC. | $151.15 | 2019-2021 | |
| Biosense Webster, INC. | $134.67 | 2025 | Carto 3 |
| Esperion Therapeutics, INC. | $117.21 | 2020-2024 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $100.19 | 2020 | |
| Cardiac Dimensions, INC. | $96.68 | 2025 | |
| Abiomed | $82.12 | 2020-2023 | Impella |
| Kiniksa Pharmaceuticals, LTD. | $78.23 | 2021-2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $77.08 | 2019-2024 | Evkeeza |
| Novo Nordisk INC | $72.56 | 2024 | Ozempic |
| Medtronic, INC. | $68.81 | 2022-2025 | Corevalve Evolut R, Mycarelink |
| Kiniksa Pharmaceuticals International, Plc | $68.39 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $61.50 | 2022-2023 | Amvuttra |
| Gilead Sciences, INC. | $55.48 | 2019 | |
| Daiichi Sankyo INC. | $49.46 | 2023 | Injectafer |
| Tactile Systems Technology INC | $46.48 | 2019-2020 | |
| Lundbeck LLC | $38.50 | 2020 | |
| Medtronic Vascular, INC. | $38.39 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $38.03 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $37.93 | 2024 | |
| Philips North America LLC | $28.96 | 2023 | |
| Impulse Dynamics (USA) INC. | $28.07 | 2022 | |
| Inari Medical, INC. | $24.37 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $21.53 | 2023 | Rotarexs 6 F X 135 Cm |
| Organogenesis INC. | $18.14 | 2020 | |
| Bolton Medical INC | $16.30 | 2019 | |
| Nevro Corp. | $15.57 | 2023 | Senza |
| Cook Medical LLC | $13.42 | 2024 | Zilver Ptx |
| Scpharmaceuticals INC. | $12.87 | 2023 | |
| Janssen Biotech, INC. | $12.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bashar Markabawi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.